Gene · 155
Papers3,802
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,341 to 1,360 of 3,802
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Stratified meta-analysis by ethnicity revealed that ADRB3 Trp64Arg polymorphism was associated with coronary artery disease in Asians, but not in Caucasians. | Medicine (Baltimore) | 2020 | 31977906 | PubTator, text mining | PubMed |
| Low-dose 18F-FDG TOF-PET/MR for accurate quantification of brown adipose tissue in healthy volunteers. | EJNMMI Res | 2020 | 31974702 | PubTator, text mining | PubMed |
| A Mouse Homolog of a Human TP53 Germline Mutation Reveals a Lipolytic Activity of p53. | Cell Rep | 2020 | 31968253 | PubTator, text mining | PubMed |
A randomized controlled study of the efficacy of tadalafil monotherapy versus combination of tadalafil and mirabegron for the treatment of persistent overactive bladder symptoms in men presenting with lower urinary tract symptoms (CONTACT Study). | Neurourol Urodyn | 2020 | 31961963 | PubTator, text mining | PubMed |
| The β3-adrenergic receptor agonist mirabegron improves glucose homeostasis in obese humans. | J Clin Invest | 2020 | 31961829 | PubTator, text mining | PubMed |
| Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity. | J Clin Invest | 2020 | 31961826 | PubTator, text mining | PubMed |
OnabotulinumtoxinA (botulinum toxin type A) for the treatment of Japanese patients with overactive bladder and urinary incontinence: Results of single-dose treatment from a phase III, randomized, double-blind, placebo-controlled trial (interim analysis). | Int J Urol | 2020 | 31957922 | PubTator, text mining | PubMed |
| Characterization of Mesenchymal Stem Cells Derived from Patients with Cerebellar Ataxia: Downregulation of the Anti-Inflammatory Secretome Profile. | Cells | 2020 | 31952198 | PubTator, text mining | PubMed |
| Treatment of ureteral catheter related symptoms; mirabegron versus tamsulosin/solifenacin combination: A randomized controlled trial. | Arch Esp Urol | 2020 | 31950924 | PubTator, text mining | PubMed |
| Alpha-Linolenic Acid-Enriched Butter Promotes Fatty Acid Remodeling and Thermogenic Activation in the Brown Adipose Tissue. | Nutrients | 2020 | 31947716 | PubTator, text mining | PubMed |
| β-blockers Reverse Agonist-Induced β2-AR Downregulation Regardless of Their Signaling Profile. | Int J Mol Sci | 2020 | 31947522 | PubTator, text mining | PubMed |
| Obesity in the Balinese is associated with FTO rs9939609 and rs1421085 single nucleotide polymorphisms. | PeerJ | 2020 | 31915589 | PubTator, text mining | PubMed |
| Changes in adipose tissue lipolysis gene expression and insulin sensitivity after weight loss. | Endocr Connect | 2020 | 31905163 | PubTator, text mining | PubMed |
| TOB1 suppresses proliferation in K-Ras wild-type pancreatic cancer. | Cancer Med | 2020 | 31891232 | PubTator, text mining | PubMed |
| Beta-1 and Not Beta-3 Adrenergic Receptors May Be the Primary Regulator of Human Brown Adipocyte Metabolism. | J Clin Endocrinol Metab | 2020 | 31867674 | PubTator, text mining | PubMed |
| Upregulation of β3-adrenoceptors-a general marker of and protective mechanism against hypoxia? | Naunyn Schmiedebergs Arch Pharmacol | 2020 | 31853614 | PubTator, text mining | PubMed |
| β3 adrenergic receptor antagonist SR59230A exerts beneficial effects on right ventricular performance in monocrotaline-induced pulmonary arterial hypertension. | Exp Ther Med | 2020 | 31853320 | PubTator, text mining | PubMed |
| Relation of ADRB3, GEF, ROCK2 gene polymorphisms to clinical findings in overactive bladder. | World J Urol | 2020 | 31802204 | PubTator, text mining | PubMed |
| Molecular signaling of G-protein-coupled receptor in chronic heart failure and associated complications. | Drug Dev Res | 2020 | 31785110 | PubTator, text mining | PubMed |
| G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action. | Pharmacol Rev | 2020 | 31767622 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/155/papers?page=68